Emerging Non-Clinical Biostatistics in Biopharmaceutical Development and Manufacturing
Yang, Harry
- 出版商: CRC
- 出版日期: 2020-12-18
- 售價: $2,380
- 貴賓價: 9.5 折 $2,261
- 語言: 英文
- 頁數: 386
- 裝訂: Quality Paper - also called trade paper
- ISBN: 0367736640
- ISBN-13: 9780367736644
-
相關分類:
機率統計學 Probability-and-statistics
海外代購書籍(需單獨結帳)
相關主題
商品描述
The premise of Quality by Design (QbD) is that the quality of the pharmaceutical product should be based upon a thorough understanding of both the product and the manufacturing process. This state-of-the-art book provides a single source of information on emerging statistical approaches to QbD and risk-based pharmaceutical development. A comprehensive resource, it combines in-depth explanations of advanced statistical methods with real-life case studies that illustrate practical applications of these methods in QbD implementation.
作者簡介
Harry Yang, Ph.D., is senior director and head of the Non-Clinical Biostatistics Group at MedImmune, the global biologics arm of AstraZeneca headquartered in Gaithersburg, Maryland.